Medical Vision
We are dedicated to developing innovative, minimally invasive treatment concepts for aortic aneurysms. Our focus is on creating smarter, more efficient stent grafts that simplify procedures, reduce operation times, and enhance patient outcomes. Our primary medical goal is to revolutionize the treatment of aortic aneurysms with next-generation stent grafts that are:
• More intelligent and adaptive
• Easier and faster to implant
• Less complex, ensuring shorter and simpler procedures
• Highly efficient, benefiting both patients and medical personnel
Economic Vision
Our economic vision is to become the leading provider of stent grafts for aortic aneurysms. We aim to introduce four innovative treatment concepts for different segments of the aorta:
• Ascending aorta
• Thoracic aorta
• Segment IV of the aorta
• Infrarenal aorta
Within the first 5 to 10 years, our goal is to make at least one of our stent grafts the market leader. To achieve this, we are actively seeking investors and offering them a share in our company.
Our Plan
Phase 1:
The first two years will be dedicated to
1. Legal and Regulatory Steps: Completing registration forms and documenting our patents to protect our innovations.
2. Seeking Investors: Attracting investors to support our production phase.
Phase 2
- Production and Marketing: Producing our stent grafts and presenting them at internationally renowned conferences and courses.
• High Growth Potential: Our cutting-edge technology and unique approach provide substantial growth opportunities in the medical field.
• Innovation: We are at the forefront of developing next-generation stent grafts, addressing critical needs in vascular surgery.
• Clear Path to Market: With our detailed roadmap, from patent registrations to product development and market introduction, your investment is secure and aimed at success.
Join Us in Shaping the Future of Medical Technology
Investing in Aortos means being part of a revolutionary journey. We are not just another startup; we are innovators with a vision to make significant impacts in healthcare. Your investment will drive us closer to our goals and ensure that you reap the benefits of our success.
Contact us
If you are interested in investment opportunities with Aortus
Khaled is a vascular surgeon and specialist. With a solid background in the use and development of stent grafts, he is committed to advancing the treatment of aortic aneurysms. Khaled is currently working on the documentation of patents for smarter, more efficient stent grafts aimed at improving patient outcomes.
Amr Hendawy, MSc
Amr is an accomplished engineer specializing in logistics and technical support. As a co-founder of Aortus, he plays a crucial role in the operational and technical development of the company.
Khaled and Amr are dedicated to revolutionizing the treatment of aortic aneurysms through innovative, minimally invasive solutions that enhance both patient care and procedural efficiency.
Unterstützt von GoDaddy